Soluble hyper-phosphorylated tau causes microtubule breakdown and functionally compromises normal tau in vivo

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397

Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.

Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676

Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells

Stambolic, V., Ruel, L., & Woodgett, J. R. (1996) · Current Biology · doi:10.1016/s0960-9822(02)70790-2 · Cited by 1,321

Differential Regulation of Dynein and Kinesin Motor Proteins by Tau

Dixit, R., Ross, J. L., Goldman, Y. E., & Holzbaur, E. L. F. (2008) · Science · doi:10.1126/science.1152993 · Cited by 1,012

Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau.

Drechsel, D. N., Hyman, A. A., Cobb, M. H., & Kirschner, M. W. (1992) · Molecular Biology of the Cell · doi:10.1091/mbc.3.10.1141 · Cited by 1,011

Tauopathy in Drosophila : Neurodegeneration Without Neurofibrillary Tangles

Wittmann, C. W., Wszolek, M. F., Shulman, J. M., Salvaterra, P. M., Lewis, J., Hutton, M., & Feany, M. B. (2001) · Science · doi:10.1126/science.1062382 · Cited by 939

Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding

Bramblett, G. T., Goedert, M., Jakes, R., Merrick, S. E., Trojanowski, J. Q., & Lee, V. M. Y. (1993) · Neuron · doi:10.1016/0896-6273(93)90057-x · Cited by 903

Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly

Cleveland, D. W., Hwo, S. Y., & Kirschner, M. W. (1977) · Journal of Molecular Biology · doi:10.1016/0022-2836(77)90214-5 · Cited by 881

Neurofibrillary tangles of Alzheimer disease share antigenic determinants with the axonal microtubule-associated protein tau (tau)

Wood, J. G., Mirra, S. S., Pollock, N. J., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.11.4040 · Cited by 763

Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease.

Alonso, A. C., Zaidi, T., Grundke-Iqbal, I., & Iqbal, K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5562 · Cited by 738

Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years

Braak, H., Thal, D. R., Ghebremedhin, E., & Del Tredici, K. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318232a379 · Cited by 2,194

The pathological process underlying Alzheimer’s disease in individuals under thirty

Braak, H., & Del Tredici, K. (2011) · Acta Neuropathologica · doi:10.1007/s00401-010-0789-4 · Cited by 812

The preclinical phase of the pathological process underlying sporadic Alzheimer’s disease

Braak, H., & Del Tredici, K. (2015) · Brain · doi:10.1093/brain/awv236 · Cited by 540

Metal Toxicity Links to Alzheimer's Disease and Neuroinflammation

Huat, T. J., Camats‐Perna, J., Newcombe, E. A., Valmas, N., Kitazawa, M., & Medeiros, R. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.01.018 · Cited by 501

Tau Protein Modifications and Interactions: Their Role in Function and Dysfunction

Mietelska‐Porowska, A., Wasik, U., Goras, M., Filipek, A., & Niewiadomska, G. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15034671 · Cited by 431

What is the evidence that tau pathology spreads through prion-like propagation?

Mudher, A., Colin, M., Dujardin, S., Medina, M., Dewachter, I., Alavi Naini, S. M., Mandelkow, E.-M., Mandelkow, E., Buée, L., Goedert, M., et al. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0488-7 · Cited by 384

Alzheimer’s pathogenesis: is there neuron-to-neuron propagation?

Braak, H., & Tredici, K. D. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0825-z · Cited by 375

Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage

Shafiei, S. S., Guerrero-Muñoz, M. J., & Castillo-Carranza, D. L. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00083 · Cited by 314

Where, when, and in what form does sporadic Alzheimerʼs disease begin?

Braak, H., & Tredici, K. D. (2012) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32835a3432 · Cited by 261

Protein phosphorylation in neurodegeneration: friend or foe?

Tenreiro, S., Eckermann, K., & Outeiro, T. F. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00042 · Cited by 252

Dietary regulation of PI3K/AKT/GSK-3β pathway in Alzheimer’s disease

Kitagishi, Y., Nakanishi, A., Ogura, Y., & Matsuda, S. (2014) · Alzheimer s Research & Therapy · doi:10.1186/alzrt265 · Cited by 252

Updates in Alzheimer's disease: from basic research to diagnosis and therapies

Liu, E., Zhang, Y., & Wang, J. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00432-x · Cited by 241

Are tau aggregates toxic or protective in tauopathies?

Cowan, C. M., & Mudher, A. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00114 · Cited by 215

Microglia rescue neurons from aggregate-induced neuronal dysfunction and death through tunneling nanotubes

Scheiblich, H., Eikens, F., Wischhof, L., Opitz, S., Jüngling, K., Cserép, C., Schmidt, S. V., Lambertz, J., Bellande, T., Pósfai, B., et al. (2024) · Neuron · doi:10.1016/j.neuron.2024.06.029 · Cited by 207

Tau-mediated disruption of the spliceosome triggers cryptic rna splicing and neurodegeneration in Alzheimer's Disease

Hsieh, Y.-C., Guo, C., Yalamanchili, H. K., Abreha, M., Al-Ouran, R., Li, Y., Dammer, E. B., Lah, J. J., Levey, A. I., Bennett, D. A., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.08.104 · Cited by 196

Tau Oligomers: The Toxic Player at Synapses in Alzheimer’s Disease

Guerrero-Muñoz, M. J., Gerson, J., & Castillo-Carranza, D. L. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00464 · Cited by 168

Intraneuronal tau aggregation precedes diffuse plaque deposition, but amyloid-β changes occur before increases of tau in cerebrospinal fluid

Braak, H., Zetterberg, H., Tredici, K. D., & Blennow, K. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1139-0 · Cited by 148

Cell-to-Cell Transmission of Tau and α-Synuclein

Uemura, N., Uemura, M. T., Luk, K. C., Lee, V. M.-Y., & Trojanowski, J. Q. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.03.012 · Cited by 149

Formation and Propagation of Tau Oligomeric Seeds

Gerson, J. E., & Kayed, R. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00093 · Cited by 140

Fibroblast growth factor 21 ameliorates neurodegeneration in rat and cellular models of Alzheimer’s disease

Chen, S., Chen, S., Sun, Y., Xu, Z., Wang, Y., Yao, S., Yao, W., & Gao, X. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101133 · Cited by 120

The Role of Protein Misfolding and Tau Oligomers (TauOs) in Alzheimer′s Disease (AD)

Mroczko, B., Groblewska, M., & Litman‐Zawadzka, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194661 · Cited by 111

Tau forms oligomeric complexes on microtubules that are distinct from tau aggregates

Gyparaki, M. T., Arab, A., Sorokina, E. M., Santiago-Ruiz, A. N., Bohrer, C. H., Xiao, J., & Lakadamyali, M. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2021461118 · Cited by 97

Alzheimer’s disease and its treatment–yesterday, today, and tomorrow

Kim, A. Y., Jerdi, S. A., MacDonald, R., & Triggle, C. R. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1399121 · Cited by 99

Stimulation of TLR4 Attenuates Alzheimer’s Disease–Related Symptoms and Pathology in Tau-Transgenic Mice

Qin, Y., Liu, Y., Hao, W., Decker, Y., Tomic, I., Menger, M. D., Liu, C., & Fassbender, K. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600873 · Cited by 90

Caspase-Cleaved Tau Impairs Mitochondrial Dynamics in Alzheimer’s Disease

Pérez, M. J., Vergara-Pulgar, K., Jara, C., Cabezas-Opazo, F., & Quintanilla, R. A. (2018) · Molecular Neurobiology · doi:10.1007/s12035-017-0385-x · Cited by 81

Neurotrophin Signaling and Stem Cells—Implications for Neurodegenerative Diseases and Stem Cell Therapy

Pramanik, S., Sulistio, Y. A., & Heese, K. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0214-7 · Cited by 77

The Ubiquitin System in Alzheimer’s Disease

Harris, L. D., Jasem, S., & Licchesi, J. D. F. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-38266-7_8 · Cited by 79

NAP (davunetide) rescues neuronal dysfunction in a Drosophila model of tauopathy

Quraishe, S., Cowan, C. M., & Mudher, A. K. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.32 · Cited by 76

Mutant Tau knock-in mice display frontotemporal dementia relevant behaviour and histopathology

Koss, D. J., Robinson, L., Drever, B. D., Plucińska, K., Stoppelkamp, S., Veselcic, P., Riedel, G., & Platt, B. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.03.002 · Cited by 76

P-tau217 correlates with neurodegeneration in Alzheimer’s disease, and targeting p-tau217 with immunotherapy ameliorates murine tauopathy

Zhang, D., Zhang, W., Chen, M., Gao, X., Yuan, H., Lin, X., Mao, X., Wang, C., Guo, X., Du, Y., et al. (2024) · Neuron · doi:10.1016/j.neuron.2024.02.017 · Cited by 75

Advances in Therapeutics for Neurodegenerative Tauopathies: Moving toward the Specific Targeting of the Most Toxic Tau Species

Gerson, J. E., Castillo‐Carranza, D. L., & Kayed, R. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn500143n · Cited by 75

Distinct phenotypes of three-repeat and four-repeat human tau in a transgenic model of tauopathy

Sealey, M. A., Vourkou, E., Cowan, C. M., Bossing, T., Quraishe, S., Grammenoudi, S., Skoulakis, E. M. C., & Mudher, A. K. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.05.003 · Cited by 77

Impaired retrograde transport by the Dynein/Dynactin complex contributes to Tau-induced toxicity

Butzlaff, M., Hannan, S. B., Karsten, P., Lenz, S., Ng, J., Voßfeldt, H., Prüßing, K., Pflanz, R., Schulz, J. B., Rasse, T. M., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv107 · Cited by 74

Modeling the complex pathology of Alzheimer's disease in Drosophila

Fernandez-Funez, P., de Mena, L., & Rincon-Limas, D. E. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.05.013 · Cited by 69

Tau is required for glial lipid droplet formation and resistance to neuronal oxidative stress

Goodman, L. D., Ralhan, I., Li, X., Lu, S., Moulton, M. J., Park, Y.-J., Zhao, P., Kanca, O., Taleghani, Z. S. G., Jacquemyn, J., et al. (2024) · Nature Neuroscience · doi:10.1038/s41593-024-01740-1 · Cited by 68

Molecular Chaperones and Regulation of Tau Quality Control: Strategies for Drug Discovery in Tauopathies

Miyata, Y., Koren, J., Kiray, J., Dickey, C. A., & Gestwicki, J. E. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.11.88 · Cited by 64

Organization and function of the FKBP52 and FKBP51 genes

Cioffi, D. L., Hubler, T. R., & Scammell, J. G. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.03.013 · Cited by 64

Rescue of neurons from undergoing hallmark tau-induced Alzheimer's disease cell pathologies by the antimitotic drug paclitaxel

Shemesh, O. A., & Spira, M. E. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.03.008 · Cited by 63

What is the pathological significance of tau oligomers?

Cowan, C. M., Quraishe, S., & Mudher, A. K. (2012) · Biochemical Society Transactions · doi:10.1042/bst20120135 · Cited by 62

Drosophila Models of Tauopathies: What Have We Learned?

Gistelinck, M., Lambert, J., Callaerts, P., Dermaut, B., & Dourlen, P. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/970980 · Cited by 60

Motifs in the tau protein that control binding to microtubules and aggregation determine pathological effects

Lathuilière, A., Valdés, P., Papin, S., Cacquevel, M., Maclachlan, C., Knott, G. W., Muhs, A., Paganetti, P., & Schneider, B. L. (2017) · Scientific Reports · doi:10.1038/s41598-017-13786-2 · Cited by 57

Microtubule-stabilizing peptides and small molecules protecting axonal transport and brain function: Focus on davunetide (NAP)

Magen, I., & Gozes, I. (2013) · Neuropeptides · doi:10.1016/j.npep.2013.10.011 · Cited by 52

Original article Hemimegalencephaly: foetal tauopathy with mTOR hyperactivation and neuronal lipidosis

Sarnat, H. B., Flores‐Sarnat, L., Crino, P. B., Hader, W. J., & Bello‐Espinosa, L. E. (2012) · Folia Neuropathologica · doi:10.5114/fn.2012.32363 · Cited by 52

Adenosine A2A receptor inactivation alleviates early-onset cognitive dysfunction after traumatic brain injury involving an inhibition of tau hyperphosphorylation

Zhao, Z., Zhao, Y., Ning, Y.-L., Yang, N., Peng, Y., Li, P., Chen, X.-Y., Liu, D., Wang, H., Chen, X., et al. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.98 · Cited by 55

Unfolded protein response activates glycogen synthase kinase-3 via selective lysosomal degradation

Nijholt, D. A. T., Nölle, A., van Haastert, E. S., Edelijn, H., Toonen, R. F. G., Hoozemans, J. J. M., & Scheper, W. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.01.008 · Cited by 48

Age-dependent increases in tau phosphorylation in the brains of type 2 diabetic rats correlate with a reduced expression of p62

Jung, H.-J., Kim, Y.-J., Eggert, S., Chung, K. C., Choi, K. S., & Park, S. A. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.07.013 · Cited by 47

Ginkgo biloba Extract EGb 761 and Its Specific Components Elicit Protective Protein Clearance Through the Autophagy-Lysosomal Pathway in Tau-Transgenic Mice and Cultured Neurons

Qin, Y., Zhang, Y., Tomic, I., Hao, W., Menger, M. D., Liu, C., Fassbender, K. C., & Liu, Y. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180426 · Cited by 47

Brain-penetrant microtubule-stabilizing compounds as potential therapeutic agents for tauopathies

Brunden, K. R., Ballatore, C., Lee, V. M. ‐., Smith, A. B., & Trojanowski, J. Q. (2012) · Biochemical Society Transactions · doi:10.1042/bst20120010 · Cited by 46

Reducing the Levels of Akt Activation by PDK1 Knock-in Mutation Protects Neuronal Cultures against Synthetic Amyloid-Beta Peptides

Yang, S., Pascual-Guiral, S., Landete, R. P., Giménez‐Llort, L., Baltrons, M. A., Arancio, O., Palacio, J. R., Clos, M. V., Yuste, V. J., & Bayascas, J. R. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00435 · Cited by 46

Increased pro–nerve growth factor and decreased brain-derived neurotrophic factor in non–Alzheimer's disease tauopathies

Belrose, J. C., Masoudi, R., Michalski, B., & Fahnestock, M. L. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.08.029 · Cited by 43

Rescue from tau-induced neuronal dysfunction produces insoluble tau oligomers

Cowan, C. M., Quraishe, S., Hands, S. L., Sealey, M. A., Mahajan, S., Allan, D. W., & Mudher, A. K. (2015) · Scientific Reports · doi:10.1038/srep17191 · Cited by 41

Tanshinone IIA Ameliorates Spatial Learning and Memory Deficits by Inhibiting the Activity of ERK and GSK-3β

Li, L., Jadoon, S. S., Liu, S.-Z., Zhang, R., Li, F., Zhang, M.-Y., Ai-Hua, T., You, Q., & Wang, P. (2019) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988719837373 · Cited by 38

Types of memory, dementia, Alzheimer’s disease, and their various pathological cascades as targets for potential pharmacological drugs

Akhtar, A., Singh, S., Kaushik, R., Awasthi, R., & Behl, T. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102289 · Cited by 38

Abnormal energy metabolism and tau phosphorylation in the brains of middle-aged mice in response to atmospheric PM2.5 exposure

Gao, R., Ku, T., Ji, X., Zhang, Y., Li, G., & Sang, N. (2017) · Journal of Environmental Sciences · doi:10.1016/j.jes.2017.06.037 · Cited by 37

Reducing PDK1/Akt Activity: An Effective Therapeutic Target in the Treatment of Alzheimer’s Disease

Yang, S., Du, Y., Zhao, X., Wu, C., & Yu, P. (2022) · Cells · doi:10.3390/cells11111735 · Cited by 38

Retinal Dysfunction in Alzheimer’s Disease and Implications for Biomarkers

Liao, C., Xu, J., Chen, Y., & Ip, N. Y. (2021) · Biomolecules · doi:10.3390/biom11081215 · Cited by 37

Post-translational modifications in neurodegeneration

Didonna, A., & Benetti, F. (2015) · AIMS Biophysics · doi:10.3934/biophy.2016.1.27 · Cited by 36

Age-related changes in tau and autophagy in human brain in the absence of neurodegeneration

Chatterjee, S., Sealey, M. A., Ruiz, E., Pegasiou, C. M., Brookes, K. J., Green, S., Crisford, A., Duque-Vasquez, M., Luckett, E. S., Robertson, R., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0262792 · Cited by 37

Aggregation, Transmission, and Toxicity of the Microtubule-Associated Protein Tau: A Complex Comprehension

Hu, J., Sha, W., Yuan, S., Wu, J., & Huang, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241915023 · Cited by 40

Differences in Synaptic Dysfunction Between rTg4510 and APP/PS1 Mouse Models of Alzheimer’s Disease

Gelman, S., Palma, J. D., Tombaugh, G. C., & Ghavami, A. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170457 · Cited by 36

Temporally distinct phosphorylations differentiate Tau-dependent learning deficits and premature mortality in Drosophila

Papanikolopoulou, K., & Skoulakis, E. M. C. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddu726 · Cited by 33

Non-invasive, in vivo monitoring of neuronal transport impairment in a mouse model of tauopathy using MEMRI

Bertrand, A., Khan, U., Hoang, D. M., Novikov, D. S., Krishnamurthy, P., Sait, H. B. R., Little, B. W., Sigurdsson, E. M., & Wadghiri, Y. Z. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.08.065 · Cited by 33

Modification of the Drosophila model of in vivo Tau toxicity reveals protective phosphorylation by GSK3β

Povellato, G., Tuxworth, R. I., Hanger, D. P., & Tear, G. (2013) · Biology Open · doi:10.1242/bio.20136692 · Cited by 35

The Interplay Between Accumulation of Amyloid-Beta and Tau Proteins, PANoptosis, and Inflammation in Alzheimer’s Disease

Zhuang, X., Jie, L., Song, Y., Ban, R., Zhao, X., Xia, Z., Wang, Z., & Zhang, G. (2024) · NeuroMolecular Medicine · doi:10.1007/s12017-024-08815-z · Cited by 33

Single domain antibodies targeting pathological tau protein: Influence of four IgG subclasses on efficacy and toxicity

Congdon, E. E., Pan, R., Jiang, Y., Sandusky‐Beltran, L. A., Dodge, A., Lin, Y., Liu, M., Kuo, M., Kong, X., & Sigurdsson, E. M. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104249 · Cited by 33

The Fruit Fly, Drosophila melanogaster: Modeling of Human Diseases (Part II)

Allocca, M., Zola, S., & Bellosta, P. (2018) · InTech eBooks · doi:10.5772/intechopen.73199 · Cited by 32

Neuronal ageing is promoted by the decay of the microtubule cytoskeleton

Okenve-Ramos, P., Gosling, R., Chojnowska-Monga, M., Gupta, K., Shields, S., Alhadyian, H., Collie, C., Gregory, E., & Sánchez‐Soriano, N. (2024) · PLoS Biology · doi:10.1371/journal.pbio.3002504 · Cited by 29

Non-Rodent Genetic Animal Models for Studying Tauopathy: Review of Drosophila, Zebrafish, and C. elegans Models

Giong, H.-K., Subramanian, M., Yu, K., & Lee, J.-S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168465 · Cited by 31

Dynein Light Chain 1 (LC8) Association Enhances Microtubule Stability and Promotes Microtubule Bundling

Asthana, J., Kuchibhatla, A., Jana, S. C., Ray, K., & Panda, D. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.394353 · Cited by 29

Activating autophagy to eliminate toxic protein aggregates with small molecules in neurodegenerative diseases

Fu, Y., Zhang, J., Qin, R., Ren, Y., Zhou, T., Han, B., & Liu, B. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100053 · Cited by 29

Protective effects of a small molecule inhibitor ligand against hyperphosphorylated tau-induced mitochondrial and synaptic toxicities in Alzheimer disease

Pradeepkiran, J. A., Munikumar, M., Reddy, A. P., & Reddy, P. H. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab244 · Cited by 28

The Power and Richness of Modelling Tauopathies in Drosophila

Papanikolopoulou, K., & Skoulakis, E. M. C. (2011) · Molecular Neurobiology · doi:10.1007/s12035-011-8193-1 · Cited by 29

Studying tauopathies in Drosophila: A fruitful model

Sun, M., & Chen, L. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.03.029 · Cited by 27

Activity-dependent neuroprotective protein (ADNP)-end-binding protein (EB) interactions regulate microtubule dynamics toward protection against tauopathy

Ivashko‐Pachima, Y., & Gozes, I. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.07.008 · Cited by 25

Animal Models of Alzheimer’s Disease

Newman, M., Kretzschmar, D., Khan, I., Chen, M., Verdile, G., & Lardelli, M. T. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809468-6.00040-1 · Cited by 25

How do neurons age? A focused review on the aging of the microtubular cytoskeleton

Richardson, B., Goedert, T., Quraishe, S., Deinhardt, K., & Mudher, A. K. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.390974 · Cited by 27

Increased expression of three-repeat isoforms of tau contributes to tau pathology in a rat model of chronic type 2 diabetes

Jung, H. J., Park, S. S., Mok, J. O., Lee, T. K., Park, C. S., & Park, S. A. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.01.012 · Cited by 25

Modelling Tauopathies in Drosophila : Insights from the Fruit Fly

Cowan, C. M., Sealey, M. A., Quraishe, S., Targett, M.-T., Marcellus, K. A., Allan, D. W., & Mudher, A. K. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/598157 · Cited by 26

An evaluation of Drosophila as a model system for studying tauopathies such as Alzheimer’s disease

Sivanantharajah, L., Mudher, A. K., & Shepherd, D. (2019) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2019.01.001 · Cited by 23

Insights from Drosophila models of Alzheimer's disease

Cowan, C. M., Shepherd, D., & Mudher, A. K. (2010) · Biochemical Society Transactions · doi:10.1042/bst0380988 · Cited by 24

Curcumin as a Holistic Treatment for Tau Pathology

Sivanantharajah, L., & Mudher, A. K. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.903119 · Cited by 22

Astrocyte transport of glutamate and neuronal activity reciprocally modulate tau pathology in Drosophila

Kilian, J., Hsu, H.-W., Mata, K., Wolf, F. W., & Kitazawa, M. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.02.011 · Cited by 21

Advances in Alzheimer’s disease therapeutics: biochemistry, exploring bioactive compounds and novel approaches

Atoki, A. V., Aja, P. M., Ondari, E. N., & Shinkafi, T. S. (2023) · International Journal of Food Properties · doi:10.1080/10942912.2023.2243050 · Cited by 20

Akt-activated GSK3β inhibitory peptide effectively blocks tau hyperphosphorylation

Lee, E., Lee, Y., Yang, S., Gong, E. J., Kim, J., Ha, N., Jo, D., Mattson, M. P., & Lee, J. (2024) · Archives of Pharmacal Research · doi:10.1007/s12272-024-01513-1 · Cited by 19

Wild-Type, but Not Mutant N296H, Human Tau Restores Aβ-Mediated Inhibition of LTP in Tau−/− mice

Vargas-Caballero, M., Denk, F., Wobst, H. J., Arch, E., Pegasiou, C.-M., Oliver, P. L., Shipton, O. A., Paulsen, O., & Wade-Martins, R. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00201 · Cited by 18

Alzheimer’s disease: an axonal injury disease?

Liang, D., & Zhang, Z. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1264448 · Cited by 21

Effect of taxoid and nontaxoid site microtubule‐stabilizing agents on axonal transport of mitochondria in untransfected and ECFP‐htau40‐transfected rat cortical neurons in culture

Das, V., Sim, D. A., & Miller, J. H. (2014) · Journal of Neuroscience Research · doi:10.1002/jnr.23394 · Cited by 18

Disruption of Microtubule Integrity Initiates Mitosis during CNS Repair

Bossing, T., Barros, C. S., Fischer, B., Russell, S. R. H., & Shepherd, D. (2012) · Developmental Cell · doi:10.1016/j.devcel.2012.06.002 · Cited by 18

Suppression of tau‐induced phenotypes by vitamin E demonstrates the dissociation of oxidative stress and phosphorylation in mechanisms of tau toxicity

Cowan, C. M., Sealey, M. A., & Mudher, A. K. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15253 · Cited by 17

GSK3β Impairs KIF1A Transport in a Cellular Model of Alzheimer’s Disease but Does Not Regulate Motor Motility at S402

Gan, K. J., Akram, A., Blasius, T. L., Ramser, E. M., Budaitis, B. G., Gabrych, D. R., Verhey, K. J., & Silverman, M. A. (2020) · eNeuro · doi:10.1523/eneuro.0176-20.2020 · Cited by 16

Intracellular tau fragment droplets serve as seeds for tau fibrils

Soeda, Y., Yoshimura, H., Bannai, H., Koike, R., Shiiba, I., & Takashima, A. (2024) · Structure · doi:10.1016/j.str.2024.06.018 · Cited by 15

Widespread hyperphosphorylated tau in the working memory circuit early after cortical impact injury of brain (Original study)

Zhao, Z., Ning, Y., Li, P., Yang, N., Peng, Y., Xiong, R., Zhao, Y., Liu, D., Zeng, X., Chen, J., et al. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.02.002 · Cited by 15

Microtubule stabilising peptides rescue tau phenotypes in-vivo

Quraishe, S., Sealey, M. A., Cranfield, L., & Mudher, A. K. (2016) · Scientific Reports · doi:10.1038/srep38224 · Cited by 17

Quantitative live cell imaging of a tauopathy model enables the identification of a polypharmacological drug candidate that restores physiological microtubule interaction

Pinzi, L., Conze, C., Bisi, N., Torre, G. D., Soliman, A., Monteiro-Abreu, N., Trushina, N. I., Krusenbaum, A., Dolouei, M. K., Hellwig, A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45851-6 · Cited by 17

UsingDrosophilamodels of neurodegenerative diseases for drug discovery

Newman, T. A., Sinadinos, C., Johnston, A. H., Sealey, M. A., & Mudher, A. K. (2011) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2011.549124 · Cited by 14

The Drosophila model system to study tau action

Trotter, M., Stephens, T. D., McGrath, J. P., & Steinhilb, M. L. (2017) · Methods in cell biology · doi:10.1016/bs.mcb.2017.06.006 · Cited by 15

A Connected Network of Interacting Proteins Is Involved in Human-Tau Toxicity in Drosophila

Feuillette, S., Charbonnier, C., Frébourg, T., Campion, D., & Lecourtois, M. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00068 · Cited by 14

Therapeutic Targets in Alzheimer's Disease and Related Tauopathies

Corbo, C. P., & Alonso, A. D. C. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385506-0.00002-8 · Cited by 13

Tau Protein: Function and Pathology

Rosenmann, H., Blum, D. L., Kayed, R., & Ittner, L. M. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/707482 · Cited by 12

Mitotic phosphorylation of Tau/MAPT modulates cell cycle progression in prostate cancer cells

Clementi, L., Sabetta, S., Zelli, V., Compagnoni, C., Tessitore, A., Mattei, V., & Angelucci, A. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-04721-2 · Cited by 11

F1‐01‐06: Soluble hyper‐phosphorylated tau causes microtubule breakdown and poisons normal tau in vivo

Mudher, A. K. (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.05.175

O3‐05‐04: Soluble hyper‐phosphorylated tau disrupts the microtubule‐binding function of normal tau in vivo

Cowan, C. M., & Mudher, A. K. (2009) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2009.05.460 · Cited by 1

Disruption of neuronal function by soluble hyperphosphorylated tau in a Drosophila model of tauopathy

Cowan, C. M., Chee, F. C., Shepherd, D., & Mudher, A. K. (2010) · Biochemical Society Transactions · doi:10.1042/bst0380564 · Cited by 42

Drosophila models of human tauopathies indicate that Tau protein toxicity in vivo is mediated by soluble cytosolic phosphorylated forms of the protein

Feuillette, S., Miguel, L., Frébourg, T., Campion, D., & Lecourtois, M. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06663.x · Cited by 81

Important neuronal toxicity of microtubule-bound Tau in vivo in Drosophila

Talmat-Amar, Y., Arribat, Y., Redt‐Clouet, C., Feuillette, S., Bougé, A.-L., Lecourtois, M., & Parmentier, M. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr290 · Cited by 48